Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Neurons may get all the glory, but they would be nothing without glial cells. While brain cells do the heavy lifting in the ...

In this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.

Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of oxygen and nutrients, killing the cardiomyocytes there. This leads to a ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Groundbreaking research shows cells from deceased organisms transforming into new life forms with revolutionary medical potential. These tiny bio-robots could revolutionize treatments for everything ...

In a recent interview with Cleo Abram, Nvidia CEO Jensen Huang suggests there could be digital twins of actual humans in the future.

German CDMO Rentschler Biopharma is closing down its cell and gene therapy operations and shutting a facility in the UK, which could affect up to 30 employees.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Harnessing the ultrasonic vibrations of tiny viral particles is leading researchers down new paths of discovery.

Officials at Rentschler Biopharma emphasize that biologics (cell culture-based therapeutic proteins) remain central to its operations.